LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trial.

Authors :: Xue, Feng
Ma, Wei
Gao, Jixian
Chen, Jinjun
Yue, Wei
Bu, Peili
Chen, Qincong
Chen, Hao
Sheng, Jianlong
Chen, Liang
Liu, Fei
Zhu, Chuanwu
Zhong, Bihui
Li, Guang-Ming
Zhang, Jianming
Wang, Le
Cai, Qingxian
Pei, Zhaohui
Chen, Ying
Yao, Lvfeng
Source :: Journal of Hepatology. 2024 Supplement 1, Vol. 80, pS100-S101. 2p.
Publication Year :: 2024

Full Text Access

Tools